Microglia are the resident innate immune cells in the brain with a major role in orchestrating immune responses. They also provide a frontline of host defense in the central nervous …
Lysosomal acidification dysfunction has been implicated as a key driving factor in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease and …
C Ji, X Zheng, S Li, C Liu, M Yin - ACS Applied Materials & …, 2023 - ACS Publications
Photothermal therapy (PTT) has emerged as a promising strategy for the treatment of tumors. However, the intrinsic self-repair mechanism of cells and the nonspecific …
Q Sun, X Xing, H Wang, K Wan, R Fan, C Liu… - Biomedicine & …, 2024 - Elsevier
Metabolic diseases, featured with dysregulated energy homeostasis, have become major global health challenges. Patients with metabolic diseases have high probability to manifest …
M Liang, Q Wang, S Zhang, Q Lan, R Wang… - Advanced …, 2024 - Wiley Online Library
Atherosclerosis is a chronic inflammatory disease of the arterial intima and is becoming the leading cause of morbidity and mortality worldwide. There is considerable evidence that …
D Jia, Z Tian, R Wang - Ageing Research Reviews, 2023 - Elsevier
The benefits of regular physical activity are related to delaying and reversing the onset of ageing and age-related disorders, including cardiomyopathy, neurodegenerative diseases …
C Yue, D Li, S Fan, F Tao, Y Yu, W Lu, Q Chen, A Yuan… - Biomaterials, 2023 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent hepatic disease characterized as lipid accumulation, yet without any approved drug. And development of …
S Wu, X Li, M Zhou, Y Cui, W Wu, J Ping, X Guo… - Biosensors and …, 2024 - Elsevier
To study the collaboration between lipid droplets (LDs) and lysosomes, and the lipid change in nonalcoholic fatty liver disease (NAFLD), herein two pH-triggered hydrophility-adjustable …
S Jin, Y Li, T Xia, Y Liu, S Zhang, H Hu, Q Chang… - Journal of Advanced …, 2025 - Elsevier
Background Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide, whereas there is no approved drug therapy due to its …